Group 1: China Liberal Education Holdings Ltd. (CLEUF) - Class action has been initiated on behalf of stockholders due to allegations of illegal activities, including a pump-and-dump scheme involving the company's shares [7] - The class period for this action is from January 22 to January 30, 2025, with a lead plaintiff deadline of March 31, 2026 [7] - The complaint states that the fraud was revealed on January 30, 2025, leading to a stock price collapse that harmed investors by over $300 million [7] Group 2: Picard Medical, Inc. (PMI) - A class action has also been filed for stockholders of Picard Medical, citing failure to disclose involvement in a fraudulent stock promotion scheme [7] - The class period for this action is from September 2, 2025, to October 31, 2025, with a lead plaintiff deadline of April 3, 2026 [7] - On October 24, 2025, Picard's stock price fell by 70% to $3.99 per share, and it has since continued to decline to approximately $2.00 per share [7]

Core Viewpoint - The Gross Law Firm is notifying shareholders of Ramaco Resources, Inc. regarding a class action lawsuit due to alleged misleading statements and lack of significant mining activity at the Brook Mine during a specified period [1][3]. Group 1: Allegations - The complaint alleges that during the class period from July 31, 2025, to October 23, 2025, Ramaco Resources, Inc. made materially false and misleading statements [3]. - Specific allegations include that defendants had not commenced significant mining activity at the Brook Mine after groundbreaking and that no active work was taking place at the site [3]. - As a result of these actions, the company is accused of overstating development progress at the Brook Mine, leading to misleading statements about its business and operations [3]. Group 2: Class Action Details - Shareholders who purchased shares of METC during the class period are encouraged to register for the class action, with a deadline set for March 31, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. - Participation in the case does not require appointment as a lead plaintiff, and there is no cost or obligation to participate [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflated stock prices [5].

Core Viewpoint - The Blue Owl Capital Inc. class action lawsuit alleges that the company and its executives violated the Securities Exchange Act of 1934, with significant implications for investors who acquired securities during the specified class period [1][3]. Company Overview - Blue Owl Capital Inc. is identified as an alternative asset manager [2]. Allegations of the Lawsuit - The lawsuit claims that Blue Owl failed to disclose significant pressures on its asset base due to business development company (BDC) redemptions, leading to undisclosed liquidity issues and potential limitations on redemptions [3]. - Financial results reported on October 30, 2025, showed fee-related earnings of $376.2 million, missing consensus estimates, and performance revenue fell 33% year over year to $188,000, which contributed to a decline in stock price [4]. - Following a merger announcement on November 5, 2025, the stock price fell nearly 5%, with concerns raised about liquidity and redemption limitations for shareholders [5]. - An article published on November 16, 2025, indicated that OBDC II shareholders could face a 20% reduction in investment value due to the merger, leading to a further stock price decline of nearly 6% [6]. Legal Process - Investors who purchased Blue Owl securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, representing the interests of all class members [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone, and is recognized for its significant recoveries in securities class action cases [8].

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Blue Owl Capital Inc. (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”), have until February 2, 2026 to seek appointment as lead plaintiff of the Blue Owl class action lawsuit. Captioned Goldman v. Blue Owl Capital Inc., No. 25-cv-10047 (S.D.N.Y.), the Blue Owl class action lawsuit charges Blue Owl and certain of Blue Owl’ ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance related to the company's financial performance [2][5]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in agilon health between February 26, 2025, and August 4, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that agilon health and its executives made false statements and failed to disclose significant industry challenges, leading to a material overstatement of the company's financial outlook [5]. Group 2: Company Performance and Stock Impact - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, citing more severe industry headwinds than previously anticipated [6]. - Following this announcement, agilon health's stock experienced a significant decline of 51.5% on August 5, 2025 [6]. Group 3: Firm Background and Support - Faruqi & Faruqi, LLP has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [4]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding agilon health's conduct [8].

Core Viewpoint - The Fermi Inc. class action lawsuit alleges that the company and its executives made misleading statements regarding its Project Matador, leading to significant financial losses for investors following the termination of a key funding agreement [3][4][5]. Group 1: Class Action Lawsuit Details - Investors who purchased Fermi Inc. common stock during the IPO or within the specified Class Period (October 1, 2025, to December 11, 2025) can seek to be appointed as lead plaintiff by March 6, 2026 [1][6]. - The lawsuit, titled Lupia v. Fermi Inc., claims violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 [1][3]. Group 2: Allegations Against Fermi Inc. - The lawsuit alleges that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment [3]. - It is claimed that there was a significant risk of the tenant terminating its funding commitment, which ultimately occurred, leading to a $150 million loss in expected construction funding [3][4]. Group 3: Financial Impact - Following the announcement of the termination of the funding agreement, Fermi's stock price dropped nearly 34% [4]. - The stock has traded as low as $8.59 per share, representing a 59% decline from the IPO price of $21.00 per share [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Klarna Group plc regarding a class action lawsuit related to misleading statements made during the company's initial public offering (IPO) on September 10, 2025 [1][3]. Group 1: Allegations - The lawsuit alleges that Klarna's defendants issued materially false and misleading statements and failed to disclose significant risks associated with loss reserves that were expected to increase shortly after the IPO [4]. - Specifically, it is claimed that the defendants understated the risk profile of individuals taking Klarna's buy now, pay later loans, which they either knew or should have known [4]. Group 2: Class Action Details - The class period for the lawsuit includes individuals who purchased Klarna securities during the IPO registration statement and related prospectus [3]. - Shareholders are encouraged to register for the class action by February 20, 2026, to potentially be appointed as lead plaintiffs, although this is not a requirement for recovery [5]. Group 3: Firm's Commitment - The Gross Law Firm emphasizes its mission to protect investors' rights and ensure companies adhere to responsible business practices [6]. - The firm aims to recover losses for investors who suffered due to false or misleading statements that led to artificial inflation of Klarna's stock [6].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Coupang, Inc. regarding a class action lawsuit due to allegations of misleading statements and inadequate cybersecurity protocols that led to a data breach affecting customer information [1][3]. Group 1: Allegations - The complaint alleges that Coupang had inadequate cybersecurity protocols, allowing a former employee to access sensitive customer information for nearly six months without detection [3]. - The company is accused of failing to disclose the heightened risk of regulatory and legal scrutiny due to the data breach [3]. - It is claimed that when the company became aware of the data breach, it did not report it in compliance with SEC reporting rules, rendering its public statements materially false and misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as May 7, 2025, to December 16, 2025 [3]. - Shareholders are encouraged to register for the class action by February 17, 2026, to potentially be appointed as lead plaintiffs [4]. - There is no cost or obligation for shareholders to participate in the case, and they will receive updates through portfolio monitoring software [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Monteverde & Associates PC is investigating Calavo Growers, Inc. regarding its merger with Mission Produce, Inc., questioning the fairness of the proposed transaction where Calavo shareholders would receive 0.9790 shares of Mission Produce and $14.85 in cash for each share of Calavo common stock [1] Group 1: Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1] - The firm is located in the Empire State Building, New York City, and specializes in class action securities litigation [2] Group 2: Merger Details - Under the terms of the proposed merger, Calavo shareholders are expected to receive 0.9790 shares of Mission Produce common stock and $14.85 in cash for each share of Calavo common stock [1] - The investigation aims to determine if this deal is fair for Calavo shareholders [1]

Core Viewpoint - Fermi, Inc. is facing a class action lawsuit due to alleged misrepresentations regarding tenant demand and agreements related to its Project Matador, which has led to significant stock price declines [1][5][6]. Company Overview - Fermi, Inc. is an energy and AI infrastructure company focused on building large-scale nuclear reactors to support grid-independent data centers for AI companies [3]. - The company's flagship project, Project Matador, aims to provide dedicated power for AI workloads [3]. IPO and Initial Representations - Fermi completed its IPO in October 2025, claiming strong demand for Project Matador and securing a 20-year lease agreement with an investment-grade-rated tenant [4]. - The First Tenant was reported to advance up to $150 million for construction costs of Project Matador [4]. Allegations and Stock Impact - Allegations have surfaced that Fermi overstated tenant demand and misrepresented the agreement with the First Tenant [5]. - Following the termination of the Advance in Aid of Construction Agreement by the First Tenant, Fermi's stock price dropped by $5.16, or over 33%, from $15.25 to $10.09 per share [6].